/
Unless otherwise indicated or unless the context otherwise requires, all references in this Form 10-K to the Company, we, us, our, and similar expressions are references to Greenlight Capital Re, Ltd. and its consolidated subsidiaries. Unless otherwise indicated or unless the context otherwise requires, all references in this Annual Report to entity names are as set forth in the following table…
$17.06
$0.01 (-0.06%)
Live · 05:19 PM
Net margin is thin at 10.25%. This may reflect rising credit costs, rate compression, or operational inefficiency.
Revenue growth slowed to 4.8%, essentially flat. This is a business that needs a catalyst.
Financial stocks carry unique risks (credit cycles, regulatory changes, interest rate sensitivity) that aren't captured by standard quality metrics.
7.2x earnings. Below the sector average, the market may be pricing in credit losses or regulatory headwinds, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$706M
▲ +4.8% YoY
Net Income (TTM)
$81M
▲ +74.8% YoY
Net Margin
11.46%
P/E
7.2x
Balance Sheet
Total Assets
$2.27B
Equity
$741M
Total Debt
$5M
Cash & Equiv.
$75M
5Y CAGR: +9.2%
Continue Research
At a P/E of 7.2 and a price-to-free-cash-flow of 2.5, Greenlight Capital Re (GLRE) trades below a two-stage DCF intrinsic value of about $352.24 per share, so at $17.06 the stock looks undervalued (1,964.7% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Greenlight Capital Re scores 94/100 on Intrinsiqq's quality scorecard (a high-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $352.24 per share for GLRE, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $264.18. At today's $17.06, that puts the stock about 1,964.7% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Greenlight Capital Re scores 94 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a high-quality business on these measures. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. GLRE currently trades below its estimated intrinsic value and scores 94/100 on quality (high-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.